Assetmark Inc. lowered its holdings in Docusign Inc. (NASDAQ:DOCU – Free Report) by 65.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 198,427 shares of the company’s stock after selling 372,050 shares during the period. Assetmark Inc. owned about 0.10% of Docusign worth $13,572,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. NewEdge Advisors LLC grew its position in Docusign by 36.4% during the first quarter. NewEdge Advisors LLC now owns 9,202 shares of the company’s stock valued at $749,000 after buying an additional 2,457 shares during the period. Guggenheim Capital LLC grew its position in shares of Docusign by 6.7% during the 2nd quarter. Guggenheim Capital LLC now owns 11,543 shares of the company’s stock valued at $899,000 after acquiring an additional 729 shares during the period. State Street Corp increased its stake in shares of Docusign by 3.0% during the 2nd quarter. State Street Corp now owns 8,074,976 shares of the company’s stock worth $628,960,000 after purchasing an additional 236,494 shares during the last quarter. Sei Investments Co. increased its stake in shares of Docusign by 60.7% during the 2nd quarter. Sei Investments Co. now owns 40,386 shares of the company’s stock worth $3,146,000 after purchasing an additional 15,247 shares during the last quarter. Finally, Treasurer of the State of North Carolina raised its holdings in shares of Docusign by 51.0% in the 2nd quarter. Treasurer of the State of North Carolina now owns 189,178 shares of the company’s stock worth $14,735,000 after purchasing an additional 63,911 shares during the period. Institutional investors own 77.64% of the company’s stock.
Docusign Stock Performance
Shares of NASDAQ DOCU opened at $46.06 on Friday. The stock has a market cap of $8.96 billion, a PE ratio of 31.12, a price-to-earnings-growth ratio of 1.79 and a beta of 0.99. Docusign Inc. has a fifty-two week low of $40.16 and a fifty-two week high of $94.67. The stock has a fifty day moving average of $46.34 and a 200-day moving average of $59.49.
Docusign declared that its board has authorized a stock repurchase program on Tuesday, March 17th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to buy up to 21% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s board believes its stock is undervalued.
Insider Buying and Selling
In related news, insider Robert Chatwani sold 16,696 shares of the company’s stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $48.10, for a total transaction of $803,077.60. Following the sale, the insider owned 72,458 shares of the company’s stock, valued at approximately $3,485,229.80. This represents a 18.73% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider James P. Shaughnessy sold 12,000 shares of the stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $46.83, for a total transaction of $561,960.00. Following the completion of the sale, the insider owned 53,631 shares in the company, valued at $2,511,539.73. This represents a 18.28% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 64,673 shares of company stock valued at $3,077,699 in the last three months. Insiders own 1.01% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts have issued reports on the company. Needham & Company LLC restated a “hold” rating on shares of Docusign in a research note on Tuesday, March 10th. Robert W. Baird decreased their price objective on Docusign from $75.00 to $55.00 and set a “neutral” rating for the company in a report on Wednesday, March 18th. BTIG Research restated a “buy” rating and issued a $70.00 price objective on shares of Docusign in a research note on Wednesday, March 18th. Jefferies Financial Group downgraded shares of Docusign from a “buy” rating to a “hold” rating and dropped their price objective for the company from $105.00 to $45.00 in a report on Monday, February 23rd. Finally, Royal Bank Of Canada cut their target price on shares of Docusign from $70.00 to $55.00 and set a “sector perform” rating for the company in a research report on Wednesday, March 18th. Four analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $61.40.
Check Out Our Latest Stock Analysis on DOCU
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Read More
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
